Q1 2026 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2026-05-15 · accession 0001892688-26-000076
$587.7M
Reported value
144
Positions
2026-03-31
Period end
The Brief · DIADEMA PARTNERS LP · Q1 2026
AI · grounded in 13F
DIADEMA PARTNERS LP closed its position in XBI for a reduction of $30.48M. The fund also exited positions in PRAX and Avidity Biosciences Inc, totaling $29.65M and $23.66M respectively. On the buy side, the fund established new positions in BridgeBio Pharma Inc [[stock:BBIO 1.75 03/01/31]] for $18.57M and CYTK for $16.48M. Additionally, the fund increased its holdings in LQDA by 3,154.42%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $41.6M | 7.07% | 93,100 | CALL | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $25.0M | 4.25% | 662,100 | CALL | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $23.8M | 4.06% | 40,200 | CALL | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $21.5M | 3.65% | 659,200 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $19.0M | 3.22% | 623,400 | PUT | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $18.7M | 3.19% | 222,500 | CALL | SOLE |
| 10806XAJ1 | BBIO 1.75 03/01/31 | BRIDGEBIO PHARMA INC | $18.6M | 3.16% | 250,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $17.1M | 2.91% | 525,181 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $16.2M | 2.75% | 27,303 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.2M | 2.24% | 200,000 | PUT | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $13.1M | 2.24% | 53,771 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $12.4M | 2.11% | 322,764 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $12.2M | 2.08% | 125,500 | PUT | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $12.0M | 2.05% | 100,000 | PUT | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $11.9M | 2.02% | 20,000 | PUT | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $11.1M | 1.89% | 100,000 | CALL | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $11.1M | 1.89% | 100,000 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $10.4M | 1.76% | 54,755 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $10.0M | 1.70% | 329,300 | CALL | SOLE |
| 45337C102 | INCY | INCYTE CORP | $9.9M | 1.69% | 105,400 | PUT | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $9.6M | 1.63% | 181,752 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $9.4M | 1.60% | 246,900 | PUT | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $9.3M | 1.58% | 335,800 | PUT | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.4M | 1.42% | 148,229 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $8.2M | 1.40% | 75,944 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $8.1M | 1.38% | 159,400 | PUT | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $7.9M | 1.34% | 80,872 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $7.4M | 1.25% | 192,962 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $7.3M | 1.25% | 78,029 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $6.9M | 1.17% | 206,928 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.7M | 1.14% | 212,500 | CALL | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $6.4M | 1.09% | 158,500 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.3M | 1.08% | 85,311 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $6.1M | 1.05% | 127,500 | PUT | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $5.8M | 0.99% | 193,189 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $5.5M | 0.94% | 6,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $5.2M | 0.89% | 24,058 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $5.1M | 0.88% | 238,142 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $5.1M | 0.86% | 106,300 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $4.9M | 0.83% | 299,000 | PUT | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.1M | 0.70% | 439,957 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $4.1M | 0.70% | 250,000 | CALL | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $3.6M | 0.61% | 244,811 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $3.6M | 0.61% | 142,132 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.5M | 0.60% | 459,900 | PUT | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.5M | 0.59% | 72,234 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.3M | 0.56% | 50,000 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.1M | 0.53% | 53,100 | CALL | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $3.1M | 0.52% | 187,307 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $2.9M | 0.49% | 179,738 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.7M | 0.46% | 317,000 | CALL | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $2.6M | 0.44% | 92,864 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $2.6M | 0.44% | 200,000 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $2.4M | 0.41% | 78,851 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $2.3M | 0.39% | 178,545 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $2.2M | 0.38% | 476,424 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $2.2M | 0.37% | 100,000 | CALL | SOLE |
| 45579U109 | INDV | INDIVIOR PHARMACEUTICALS INC | $2.2M | 0.37% | 71,376 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $2.1M | 0.35% | 55,900 | PUT | SOLE |
| 15102K100 | CELC | CELCUITY INC | $2.0M | 0.34% | 17,700 | CALL | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $2.0M | 0.33% | 286,126 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $2.0M | 0.33% | 353,200 | CALL | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $1.9M | 0.33% | 352,399 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $1.9M | 0.32% | 293,664 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $1.9M | 0.32% | 50,000 | PUT | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $1.8M | 0.31% | 25,942 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.8M | 0.30% | 50,000 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $1.7M | 0.30% | 600,000 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $1.7M | 0.29% | 3,840 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $1.6M | 0.28% | 423,642 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $1.6M | 0.27% | 205,500 | CALL | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.6M | 0.26% | 106,300 | CALL | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC. | $1.5M | 0.25% | 316,000 | CALL | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $1.5M | 0.25% | 477,600 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.5M | 0.25% | 25,071 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $1.4M | 0.24% | 200,842 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $1.4M | 0.23% | 106,300 | CALL | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $1.3M | 0.23% | 241,300 | CALL | SOLE |
| 81642T209 | SLS | SELLAS LIFE SCIENCES GROUP I | $1.3M | 0.22% | 300,000 | CALL | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.3M | 0.21% | 84,000 | CALL | SOLE |
| 21900C308 | CRMD | CORMEDIX INC | $1.1M | 0.19% | 167,500 | PUT | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.1M | 0.18% | 115,300 | CALL | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.1M | 0.18% | 300,000 | CALL | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $1.0M | 0.18% | 60,000 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $979,037 | 0.17% | 562,665 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $963,900 | 0.16% | 353,077 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $867,688 | 0.15% | 433,844 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $839,200 | 0.14% | 10,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $828,318 | 0.14% | 29,321 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $820,344 | 0.14% | 64,952 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $815,321 | 0.14% | 106,300 | PUT | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $795,648 | 0.14% | 88,800 | CALL | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $770,049 | 0.13% | 100,660 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $769,927 | 0.13% | 132,746 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $749,867 | 0.13% | 166,637 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $736,355 | 0.13% | 132,916 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $736,267 | 0.13% | 35,144 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $713,740 | 0.12% | 26,347 | Common | SOLE |
| 90466Y202 | UNCY | UNICYCIVE THERAPEUTICS INC | $698,026 | 0.12% | 106,083 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $687,336 | 0.12% | 31,200 | PUT | SOLE |
| 85209E208 | SPRB | SPRUCE BIOSCIENCES INC | $653,500 | 0.11% | 10,000 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $607,162 | 0.10% | 54,650 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $606,540 | 0.10% | 5,314 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $579,000 | 0.10% | 150,000 | CALL | SOLE |
| 67577C105 | OCGN | OCUGEN INC | $543,000 | 0.09% | 300,000 | CALL | SOLE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $525,808 | 0.09% | 200,690 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $520,736 | 0.09% | 14,577 | Common | SOLE |
| 171126204 | PTHS | PELTHOS THERAPEUTICS INC | $520,481 | 0.09% | 24,773 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $514,572 | 0.09% | 125,200 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $510,120 | 0.09% | 31,200 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $457,177 | 0.08% | 186,603 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $447,750 | 0.08% | 15,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $439,240 | 0.07% | 31,600 | CALL | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $416,327 | 0.07% | 23,155 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $403,100 | 0.07% | 10,000 | Common | SOLE |
| 53630X203 | LPCN | LIPOCINE INC NEW | $399,500 | 0.07% | 50,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $382,132 | 0.07% | 79,944 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $377,314 | 0.06% | 26,836 | Common | SOLE |
| 67577C105 | OCGN | OCUGEN INC | $362,000 | 0.06% | 200,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $291,734 | 0.05% | 180,083 | Common | SOLE |
| 29842P105 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $289,600 | 0.05% | 40,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $267,137 | 0.05% | 150,925 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $258,440 | 0.04% | 21,663 | Common | SOLE |
| 74017N105 | PGEN | PRECIGEN INC | $213,984 | 0.04% | 55,293 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $194,481 | 0.03% | 21,609 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $176,324 | 0.03% | 31,885 | Common | SOLE |
| 702712209 | PASG | PASSAGE BIO INC | $153,311 | 0.03% | 19,530 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $130,848 | 0.02% | 75,200 | CALL | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $114,696 | 0.02% | 153,563 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $109,473 | 0.02% | 30,579 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $89,308 | 0.02% | 1,630 | Common | SOLE |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $82,246 | 0.01% | 4,100 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $60,252 | 0.01% | 105,428 | Common | SOLE |
| 04965N104 | RNA | ATRIUM THERAPEUTICS INC | $33,585 | 0.01% | 2,512 | Common | SOLE |
| 22978P106 | CUE1EUR | CUE BIOPHARMA INC | $30,346 | 0.01% | 131,997 | Common | SOLE |
| M40527109 | ENTX | ENTERA BIO LTD | $25,819 | 0.00% | 23,260 | Common | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $11,327 | 0.00% | 7,924 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $10,179 | 0.00% | 2,900 | PUT | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $9,750 | 0.00% | 12,500 | PUT | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $9,604 | 0.00% | 245 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $9,516 | 0.00% | 12,200 | CALL | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $7,624 | 0.00% | 200 | CALL | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $4,854 | 0.00% | 202 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $2,930 | 0.00% | 1,046 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.